SCHEMBL7201940

SCHEMBL7201940

CS(=O)(=O)c1cccc(-c2nnc(SCCCN3CCc4ccc(S(=O)(=O)N5CCCC5)cc4C3)n2C2CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.49
NPSR1 Q6W5P4 3/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 4/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
DRD2 P14416 10/20 0.38
DRD3 P35462 10/20 0.38
KCNH2 Q12809 7/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 1/20 0.36
APEX1 P27695 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382322 0.93 ALDH1A1 (0.43) GAANPSR1LMNAHTTALDH1A1
SCHEMBL4397044 0.90 DRD2 (0.45) GAANPSR1LMNAHTTCYP1A2
SCHEMBL4382683 0.84 DRD3 (0.42) GAANPSR1LMNAHTTCYP1A2
SCHEMBL4392626 0.81 DRD3 (0.58) HTTALDH1A1KDM4EHPGDDRD2
SCHEMBL4385475 0.81 DRD3 (0.60) HTTALDH1A1KDM4EHPGDDRD2
SCHEMBL4394660 0.81 DRD3 (0.60) HTTALDH1A1KDM4EHPGDDRD2
SCHEMBL4386866 0.79 DRD3 (0.55) CYP3A4ALDH1A1KDM4EHPGDDRD2
SCHEMBL4386303 0.77 DRD3 (0.55) ALDH1A1KDM4EHPGDDRD2DRD3
SCHEMBL4395670 0.76 DRD3 (0.56) HTTALDH1A1KDM4EHPGDDRD2
SCHEMBL4395503 0.75 DRD3 (0.50) ALDH1A1KDM4EHPGDDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602867-B1 Triazole compounds with dopamine-D3-receptor affinity ABBOTT LABORATORIES 2003-08-05 US disclosed